News
10-29-2011, 01:50 AM
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today announced the presentation of promising preclinical data with palifosfamide in a pediatric sarcoma model.
More... (http://www.news-medical.net/news/20111029/ZIOPHARM-reports-promising-preclinical-data-with-palifosfamide-in-pediatric-sarcoma-model.aspx)
More... (http://www.news-medical.net/news/20111029/ZIOPHARM-reports-promising-preclinical-data-with-palifosfamide-in-pediatric-sarcoma-model.aspx)